Wire Stories

Coeur Provides Palmarejo Exploration Update

CHICAGO–(BUSINESS WIRE)–Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE: CDE) today provided an update on the exploration programs at its Palmarejo gold-silver...

387

Global Economic Boom Boosts Commercial Banks Revenue, Set to Reach $2.8 Trillion in 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Commercial Banks – Industry Market Research Report” has been added to ResearchAndMarkets.com’s offering. The industry closely follows global economic...

489

Anteris Technologies Commences American Depository Receipt Program

BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)–Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that it has established a...

417

Options Chosen as Primary Market Data Provider for GO Markets’ Expansion into Asian Markets

LONDON & NEW YORK & HONG KONG–(BUSINESS WIRE)–Options Technology, the leading provider of financial technology and global market data solutions, today announced...

417

Anteris Technologies Commences US Early Feasibility Study

BRISBANE, Australia & MINNEAPOLIS–(BUSINESS WIRE)–Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ Transcatheter Heart...

430

Coca-Cola Bottlers Japan and Accenture to Establish Joint Venture

The new entity will promote data-driven management by streamlining administrative and back-office operations of Coca-Cola Bottlers Japan Group TOKYO–(BUSINESS WIRE)–Coca-Cola Bottlers Japan...

387

Parade Technologies Reports Second Quarter 2023 Financial Results

Financial Highlights: Q223 consolidated revenue US$104.18 million, compared with US$216.70 million in the year-ago quarter Q223 consolidated net income US$13.98 million; Basic...

509

Meiji Seika Pharma Announces Positive Results in Phase II Study of ME3183, a Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Moderate-to-Severe Plaque Psoriasis in the United States and Canada

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi) today announced that ME3183, a novel highly-potent selective...